SCHEMBL8287259

SCHEMBL8287259

CC(=O)CCc1cncc2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.34
MAPK1 P28482 2/20 0.34
HPGD P15428 1/20 0.34
GFER P55789 1/20 0.34
PDE11A Q9HCR9 1/20 0.34
RIPK1 Q13546 2/20 0.34
CSF1R P07333 1/20 0.34
KDM4E B2RXH2 1/20 0.32
HTT P42858 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
PLA2G4A P47712 1/20 0.32
MAPK13 O15264 1/20 0.32
MAPK12 P53778 1/20 0.32
MAPK11 Q15759 1/20 0.32
MAPK14 Q16539 1/20 0.32
MAPT P10636 2/20 0.32
HSD11B1 P28845 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286455 0.92 PLA2G4A (0.37) GAAMAPK1HPGDGFERPDE11A
SCHEMBL8286552 0.90 CCNC (0.37) GAAMAPK1HPGDGFERPDE11A
SCHEMBL8287263 0.90 TSHR (0.40) GAAMAPK1HPGDGFERPDE11A
SCHEMBL8287273 0.90 PDE11A (0.34) GAAMAPK1HPGDGFERPDE11A
SCHEMBL8287270 0.89 HSD11B1 (0.40) GAAGFERPDE11AMAPTHSD11B1
SCHEMBL8286560 0.89 MAPT (0.39) GAAHPGDKDM4EHTTALDH1A1
SCHEMBL8287501 0.86 GAA (0.39) GAAMAPK1HPGDGFERPDE11A
SCHEMBL8286557 0.85 NPC1 (0.40) GAAPDE11AKDM4EMEN1KMT2A
SCHEMBL8286554 0.85 ALDH1A1 (0.35) GAAMAPK1HPGDPDE11AMEN1
SCHEMBL8286175 0.85 GAA (0.36) GAAMAPK1HPGDGFERPDE11A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed